Alnylam Pharmaceuticals, Inc. (ALNY) on GreekSoup https://greeksoup.ai/stocks/us/alny/ Every dated entry in the public record on Alnylam Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Alnylam Pharmaceuticals, Inc.: short interest 6,568,786 shares at the 15 October 2026 settlement, 5.10 days to coverhttps://greeksoup.ai/stocks/us/alny/short-interest/us:ALNY:short-interest:2026-10-15:f03adabe69Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: Supran Bryan (EVP, CLO and Secretary) sold 1,758 shares at $226.88 on 2 October 2026, $398,855https://greeksoup.ai/stocks/us/alny/insiders/us:ALNY:insider:2026-10-06:c1e6e6f0bcTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: Form 144, SUPRAN BRYAN plans to sell 1,758 shares worth $398,862 around 2 October 2026https://greeksoup.ai/stocks/us/alny/planned-sales/us:ALNY:planned-sale:2026-10-02:3b157b4040Fri, 02 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: short interest 7,711,495 shares at the 30 September 2026 settlement, 6.45 days to coverhttps://greeksoup.ai/stocks/us/alny/short-interest/us:ALNY:short-interest:2026-09-30:8356450804Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: short interest 7,194,097 shares at the 15 September 2026 settlement, 4.13 days to coverhttps://greeksoup.ai/stocks/us/alny/short-interest/us:ALNY:short-interest:2026-09-15:ca89bee470Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: short interest 6,340,087 shares at the 31 August 2026 settlement, 3.90 days to coverhttps://greeksoup.ai/stocks/us/alny/short-interest/us:ALNY:short-interest:2026-08-31:99d4717586Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: short interest 4,770,978 shares at the 14 August 2026 settlement, 2.36 days to coverhttps://greeksoup.ai/stocks/us/alny/short-interest/us:ALNY:short-interest:2026-08-14:00231ef056Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc.: short interest 4,803,194 shares at the 31 July 2026 settlement, 2.18 days to coverhttps://greeksoup.ai/stocks/us/alny/short-interest/us:ALNY:short-interest:2026-07-31:0c82828937Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc. Q2 FY2026 results: revenue $1.3 billion, net income $164 millionhttps://greeksoup.ai/stocks/us/alny/results/fy2026-q2/us:ALNY:result:2026-07-30:7d9b54897fThu, 30 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/alny/filings/us:ALNY:filing:2026-07-30:9525170f51Thu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Alnylam Pharmaceuticals, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/alny/filings/us:ALNY:filing:2026-07-30:2508b54e3dThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>